Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

We have optimized a novel series of potent p38 MAP kinase inhibitors based on an alpha-ketoamide scaffold through structure based design that due to their extended molecular architecture bind, in addition to the ATP site, to an allosteric pocket. In vitro ADME, in vivo PK and efficacy studies show these compounds to have drug-like characteristics and have resulted in the nomination of a development candidate which is currently in phase II clinical trials for the oral treatment of inflammatory conditions.

Knowledge Graph

Similar Paper

Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site
Bioorganic & Medicinal Chemistry Letters 2010.0
The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis
Bioorganic & Medicinal Chemistry Letters 2004.0
Design, Synthesis, and Biological Evaluation of Novel Type I<sup>1</sup>/<sub>2</sub> p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine
Journal of Medicinal Chemistry 2017.0
Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode
Bioorganic &amp; Medicinal Chemistry Letters 2008.0
Selective targeting of the αC and DFG-out pocket in p38 MAPK
European Journal of Medicinal Chemistry 2020.0
Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors
Journal of Medicinal Chemistry 2012.0
Two classes of p38α MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes
Bioorganic &amp; Medicinal Chemistry Letters 2005.0
Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity
Journal of Medicinal Chemistry 2013.0
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Journal of Medicinal Chemistry 2005.0